Binding of nitrobenzene to hepatic DNA and hemoglobin at low doses in mice

Toxicology Letters

Volumn 139, Issue 1, 2003, Pages 25-32

  Li, Hongli ^a   Wang, Haifang ^a   Sun, Hongfang ^a   Liu, Yuanfang ^a   Liu, Kexin ^b   Peng, Shixiang ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Accelerator mass spectrometry; Carcinogenesis; Hemoglobin adducts; Hepatic DNA adducts; Nitrobenzene

Indexed keywords

CARBON 14; DNA; HEMOGLOBIN; NITROBENZENE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENIC ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; GENOTOXICITY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; TOXICOKINETICS;

ANIMALS; DNA; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBINS; LIVER; MALE; MICE; NITROBENZENES; PROTEIN BINDING; TIME FACTORS;

ANIMALIA;

EID: 0037457275     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00438-1     Document Type: Article

References (31)

1. Albrecht W., Neumann H. Biomonitoring of aniline and nitrobenzene: hemoglobin binding in rats and analysis of adducts. Arch. Toxicol. 57:1985;1-5.
2. ATSDR, 1990. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Nitrobenzene. US Department of Health and Human Services, Public Health Service, Atlanta, GA.
3. Beland F.A., Poirier M.C. Significance of DNA adducts in animal models for cancer molecular dosimetry and risk assessment. Environ. Health Perspect. 99:1993;5-10.
4. Blaauboer B.J., Van Holsteijn C.W.M. Formation and disposition of N-hydroxylated metabolites of aniline and nitrobenzene by isolated rat hepatocytes. Xenobiotica. 13:1983;295-302.
5. Butterworth B.E., Smith-Oliver T., Earle L., Loury D. Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 49:1989;1075-1084.
6. Cattley R., Everitt J.I., Gross E.A., Moss O.R., Hamm T.E., Popp J.A. Carcinogenicity and toxicity of inhaled nitrobenzene in B6C3F1 mice and F344/N and CD rats. Fundam. Appl. Toxicol. 22:1994;328-340.
7. Chen C.E., Guo Z.Y., Yan S.Q., Zhang Z.F., Gong L.H., Li R.X., Yu J.K. Status of tandem accelerator mass spectrometry facility at Peking University. Nucl. Instr. Methods. B52:1990;306-309.
8. Dingley K.H., Freeman S.P.H.T., Nelson D.O., Garner R.C., Turteltaub K.W. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally-relevant doses: a comparison of humans and the F344 rat. Drug Metab. Dispos. 26:1998;825-828.
9. Eyer P., Ascherl M. Reactions of para-substituted nitrosoamines with human hemoglobin. Biol. Chem. Hoppe-Seyler. 368:1987;285-294.
10. Gupta R.C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. USA. 81:1984;6943-6947.
11. Haworth S.T., Lawlor K., Mortelmans K., Speck W., Zeiger E. Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. 5:1983;3-142.
12. Hein D.W. Acetylator phenotype and arylamine-induced carcinogenesis. Biochem. Biophys. Acta. 948:1988;37-66.
13. Hein D.W., Doll M.A., Fretland A.J., Gray K., Deitz A.C., Feng Y., Jiang W., Rustan T.D., Satran K.L., Wilkie T.R. Rodent models of human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat. Res. 376:1997;101-106.
14. Holder, J.W., 1992. Weight-of-evidence (WOE) classification for hazardous air pollutants. Internal report on the current carcinogenicity status of 37 hazardous air pollutants. Office of Health and Environmental Assessment, Office of Research and Development, US EPA, Washington, DC, September 28.
15. Holder J.W. Nitrobenzene potential human cancer risk based on animal studies. Toxicol. Ind. Health. 15:1999;458-463.
16. Howard P.C., Beland F.A., Cerniglia C.E. Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by the rat intestinal bacteria. Carcinogenesis. 4:1983;985-990.
17. Li X.S., Wang H.F., Shi J.Y., Wang X.Y., Liu Y.F. Genotoxicity study on nicotine and nicotine-derived nitrosamine by AMS. Radiocarbon. 38:1996;347-353.
18. Liu Y.F., Guo Z.Y., Liu X.Q., Qu T., Xie J.L. Applications of accelerator mass spectrometry in analysis of trace isotopes and elements. Pure Appl. Chem. 66:1994;305-334.
19. Lutz W.K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in process of chemicals carcinogenesis. Mutat. Res. 65:1979;289-356.
20. Otteneder M., Lutz W.K. Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat. Res. 424:1999;237-247.
21. Poirier M.C., Beland F.A. DNA adduct measurement and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5:1992;749-755.
22. Turteltaub K.W., Dingley K.H. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification. Toxicol. Lett. 102/103:1998;435-439.
23. Turteltaub K.W., Vogel J.S., Frantz C.E., Fultz E. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labeled DNA adduction. Philips D.H., Castegnaro M., Bartsch H. Postlabeling Methods for Detection of DNA Adducts. 1993;293-301 IARC, Lyon.
24. US EPA, 1986. Guidelines for carcinogen risk assessment. Federal Register 51, 33993-4003.
25. US EPA, 1996. Proposed guidelines for carcinogen risk assessment. Federal Register 61, 17960-8011.
26. Vance W.A., Levin D.E. Structural features of nitroaromatics that determine mutagenic activity in Salmonella typhimurium. Environ. Mutagen. 6:1984;797-811.
27. Verna L., Whysner J., Williams G.M. 2-Acetylaminofluorenemechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. Pharmacol. Ther. 71:1996;83-105.
28. Vogel J.S. Rapid production of graphite without contamination for biomedical AMS. Radiocarbon. 3:1992;344-350.
29. Vogel J.S., Turteltaub K.W., Finkel R., Nelson D.E. Accelerator mass spectrometry: Isotope identification at attomole sensitivity. Anal. Chem. 67:1995;353A-359A.
30. Wang Y., Wang H.F., Sun H.F., Wang X.Y., Liu Y.F. Accelerator mass spectrometry studies on adduction of nicotine with Hb and serum albumin in mice. Chem. J. Chin. Univ. 23:2002;809-812.
31. Wu X.H., Wang H.F., Liu Y.F. Histone adduction with nicotine: a bio-AMS study. Radiocarbon. 39:1997;293-297.